8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 5, 2007
BAUSCH & LOMB INCORPORATED (Exact name of registrant as specified in its charter)
New York	1-4105		16-0345235
(State or other jurisdiction of incorporation)	(Commission File Number)		(IRS Employer Identification No.)
One Bausch & Lomb Place, Rochester, NY		14604-2701
(Address of principal executive offices)		(Zip Code)
Registrant’s telephone number, including area code: (585) 338.6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 5, 2007, the Company announced that Paul G. Howes, currently senior vice president and president-Americas Region, intends to resign from the Company. A copy of the press release containing the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01	Financial Statements and Exhibits
(a)	Financial statements of businesses acquired. -   Not applicable
(b)	Pro forma financial information. -   Not applicable
(c)	Exhibits. The following exhibit is filed as part of this report:
	99.1Press Release dated January 5, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BAUSCH & LOMB INCORPORATED

/s/ David R. Nachbar

David R. Nachbar

Senior Vice President, Human Resources

Date: January 5, 2007

EX-99.1

Exhibit 99.1

Bausch & Lomb Announces Changes in Americas Region Commercial Management

·   Gary M. Phillips, M.D. will head U.S. Pharmaceutical and Surgical Businesses

·   Angela J. Panzarella assumes additional responsibility for Commercial Operations in Canada and Latin America

·   Robert J. Moore continues as head of U.S. Vision Care Businesses

·   Paul G. Howes resigns from Company

FOR RELEASE FRIDAY, JANUARY 5, 2007

ROCHESTER, NEW YORK - Bausch & Lomb (NYSE/BOL) today announced a realignment of management responsibilities for the Americas Region, following the announcement by Paul G. Howes, currently senior vice president and president-Americas Region that he intends to resign from the company to pursue career opportunities elsewhere. Howes will remain with Bausch & Lomb to effect an orderly transition to the new management structure.

Gary M. Phillips, M.D. will head the U.S. pharmaceutical and surgical businesses. Currently corporate vice president-global pharmaceuticals, Phillips joined Bausch & Lomb in 2002 from Novartis Pharmaceuticals. An announcement regarding Phillips’ replacement as head of global strategy for the pharmaceuticals business will be made at a later date.

Angela J. Panzarella, corporate vice president-global vision care, will assume responsibility for the commercial operations in Canada and Latin America in addition to her current responsibility for global strategy for the contact lens and lens care businesses. Panzarella has been with Bausch & Lomb since 1988 and was named to her current position in 2001.

Robert J. Moore will continue in his position as vice president and general manager of the U.S. vision care and OTC eye care business, a position he has held since 2004.

“One of the hallmarks of Paul Howes’ tenure with Bausch & Lomb was his passionate focus on developing and maintaining excellent customer relationships,” said Ronald L. Zarrella, chairman and CEO of the company. “We appreciate his willingness to help us manage a smooth transition to the new structure and wish him continued success in the future.”

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb employs approximately 13,700 people worldwide and its products are available in more than 100 countries. More information about the Company is on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.